Inventor · Fairfax, VA, US

Ronnie C. Mease

41Patents
12h-index
31Co-inventors
81Inventor score

Filing activity: Jun 29, 1989 → Aug 11, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US8778305B2 PSMA-binding agents and uses thereof Emerging Cross-Sectional Technologies 75 Active
US9226981B2 PSMA-binding agents and uses thereof Emerging Cross-Sectional Technologies 46 Active
US9056841B2 PSMA-targeting compounds and uses thereof Physics 44 Active
US9044468B2 Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents Physics 43 Active
US5021571A Cyclohexyl EDTA monoanhydride Chemistry; Metallurgy 28 Expired
US5639879A Macrocyclic polyaminocarboxylates for stable radiometal antibody conjugates for therapy, spect and pet imaging Chemistry; Metallurgy 26 Expired
US5292938A Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging Chemistry; Metallurgy 19 Expired
US5428156A Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging Chemistry; Metallurgy 18 Expired
US9694091B2 Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents Physics 16 Active
US6022522A Rigid bifunctional chelating agents Human Necessities 16 Expired
US5334729A Stable radiometal antibody immunoconjugates Chemistry; Metallurgy 13 Expired
US9776977B2 PSMA-targeting compounds and uses thereof Physics 12 Active
US9422234B2 Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer Emerging Cross-Sectional Technologies 12 Active
US9371360B2 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof Human Necessities 11 Active
US5089663A Cyclohexyl-triethylenetetraamine hexacetic acid Chemistry; Metallurgy 9 Expired
US9884132B2 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof Human Necessities 8 Active
US9861713B2 PSMA-binding agents and uses thereof Emerging Cross-Sectional Technologies 7 Active
US10500292B2 PSMA-binding agents and uses thereof Emerging Cross-Sectional Technologies 6 Active
US5635157A Synthesis of 4-substituted-trans-1,2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging Chemistry; Metallurgy 6 Expired
US10683272B2 Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy Human Necessities 5 Active
US10039845B2 Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents Physics 5 Active
US10232058B2 Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy Chemistry; Metallurgy 5 Active
US10736974B2 Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy Human Necessities 4 Active
US10717750B2 68Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agents Human Necessities 4 Active
US10653806B2 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof Human Necessities 4 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.